SEC Form 4 · accession 0001179110-17-011052
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon J Bracken
Officer — Senior Vice President
Period of report
Aug 1, 2017
Accepted (ET)
Aug 3, 2017 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Aug 1, 2017 | S | 400 | $49.165 | D | 28,806 | D | |
| Common shares without par value | Aug 1, 2017 | S | 600 | $49.16 | D | 28,206 | D | |
| Common shares without par value | Aug 1, 2017 | S | 1,000 | $49.161 | D | 27,206 | D | |
| Common shares without par valueF1 | holding | — | — | — | 736 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of August 1, 2017.